ReWalk Joins Israeli Technology Innovation Consortium for Human-Robot Interaction
The MAGNET Consortium program led by Israel’s Innovation Authority fosters collaboration through R&D grantsMARLBOROUGH, Mass., April 29, 2022 (GLOBE NEWSWIRE)...
Year: 2022
Nass Valley Gardens Inc. Announces It Will Diversify Its Product Offering Which Will Include a Cosmetic Line and Hemp-Based Foods
WEST PALM BEACH, FL, April 29, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Nass Valley Gardens Inc., a Nevada registered C-Corp and...
U.S. Food and Drug Administration Approves Camzyos (mavacamten) for the Treatment of Adults with Symptomatic New York Heart Association Class II-III Obstructive Hypertrophic Cardiomyopathy (HCM) to Improve Functional Capacity and Symptoms
LianBio to Continue Development of Camzyos in China and Other Asian TerritoriesSHANGHAI and PRINCETON, N.J., April 29, 2022 (GLOBE NEWSWIRE)...
Palisade Bio to Participate in the Virtual Investor Management and KOL Roundtable Event
Live moderated video webcast discussion among members of Management and a renowned Key Opinion Leader on Tuesday, May 3rd at...
Amedisys to Present at Multiple Healthcare Conferences in May
BATON ROUGE, La., April 29, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice,...
Athenex to Provide Corporate and Financial Update for the First Quarter 2022 on May 10, 2022
BUFFALO, N.Y., April 29, 2022 (GLOBE NEWSWIRE) -- Athenex (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development,...
ORYZON to Give Updates on Corporate Progress in May
Swiss Biotech DayLSX World Congress BioEquity Europe H.C. Wainwright Global Investment ConferencePrecisionMed Expo & Summit Foro MedCap BMEMADRID, Spain and...
BioRestorative Therapies Hosts Principal Investigator Meeting for its BRTX-100® Phase 2 Clinical Trial to Treat Chronic Lumbar Disc Disease
MELVILLE, N.Y., April 29, 2022 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company” or “BioRestorative”) (NASDAQ: BRTX), a clinical stage...
Lexicon Pharmaceuticals to Host First Quarter 2022 Financial Results Conference Call and Webcast on May 5, 2022
THE WOODLANDS, Texas, April 29, 2022 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), will release its first quarter 2022...
Sight Sciences to Present at the Upcoming Bank of America Healthcare Conference
MENLO PARK, Calif., April 29, 2022 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) an eyecare technology company focused on...
Zymergen to Participate in the BofA Securities 2022 Healthcare Conference
EMERYVILLE, Calif., April 29, 2022 (GLOBE NEWSWIRE) -- Zymergen Inc. (“Zymergen” or the “Company”), today announced the company will be...
Covetrus Announces First Quarter 2022 Earnings Release Date and Conference Call Information
PORTLAND, Maine--(BUSINESS WIRE)--Covetrus® (NASDAQ: CVET), a global leader in animal-health technology and services, announced today that it will release first...
iZafe Group Q1 Interim Report, January-March 2022
STOCKHOLM, SE / ACCESSWIRE / April 29, 2022 / iZafe Group (STO:IZAFE-B)iZafe Group AB (publ.) - today April 29, releases...
Awakn Life Sciences Reports Fiscal Fourth Quarter and Fiscal Year January 31, 2022, Results
Toronto, Ontario--(Newsfile Corp. - April 28, 2022) - Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) ('Awakn'), a...
Sibannac’s Campus Co. Division Lands Icon Coca-Cola Beverages Northeast and Other Innovator Brands in the Beverage, Food and Spirits Markets
Scottsdale, Arizona--(Newsfile Corp. - April 28, 2022) - Sibannac, Inc. (OTC Pink: SNNC), a Nevada corporation (the "Company"), announced the...
Invitation to MorphoSys’ First Quarter 2022 Financial Results Conference Call on May 5, 2022
PLANEGG/MUNICH, GERMANY / ACCESSWIRE / April 28, 2022 / MorphoSys AG (FSE:MOR)(NASDAQ:MOR) will publish its results for the first quarter...
Cloud DX Announces Investor Event to Recap Financials and Q1 Growth
KITCHENER, ON / ACCESSWIRE / April 28, 2022 / Cloud DX (TSXV:CDX) (OTC:CDXFF), a leader in Virtual Care and Digital...
Abivax Publishes Universal Registration Document 2022 ‘Document d’Enregistrement Universel’
PARIS, FRANCE / ACCESSWIRE / April 28, 2022 / Abivax SA (Euronext Paris: FR0012333284 - ABVX), a clinical-stage biotechnology company...
Leveljump Announces Fiscal 2021 Earnings and Results
Toronto, Ontario--(Newsfile Corp. - April 28, 2022) - Leveljump Healthcare Corp. (TSXV: JUMP) (OTCQB: JMPHF) (FSE: 75J) ("Leveljump" or the...
Neovasc Comments on European Heart Journal Publication
Report demonstrates objective improvements in patients suffering from microvascular dysfunctionVancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - April 28, 2022)...